One study in mice demonstrated neuroprotection when an sEH inhibitor was administered within 5 min of ROSC [16], and other stroke models have suggested a greater benefit when sEH inhibitor is administered earlier, such as before injury [13, 27, 38], at the onset of ischemia [28], or at the time of reperfusion [15]. This evidence concerns the gene EPHX2 and stroke disorder.